Literature DB >> 24942866

Caught in the cross fire: p53 in inflammation.

Tomer Cooks1, Curtis C Harris2, Moshe Oren3.   

Abstract

The p53 transcription factor is a major tumor suppressor, whose diverse activities serve to ensure genome stability and inhibit neoplastic processes. In recent years, it is becoming increasingly clear that p53 also plays a broader role in maintaining cellular homeostasis, as well as contributing to tissue homeostasis in a non-cell-autonomous fashion. Chronic inflammation is a potential cancer-promoting condition, and as such is also within the radar of p53, which mounts a multifaceted attempt to prevent the escalation of chronic tissue imbalance into neoplasia. Recent understanding of the p53 pathway and other family members reveals a broad interaction with inflammatory elements such as reactive oxygen and nitrogen species, cytokines, infectious agents and major immune-regulatory pathways like nuclear factor-kappaB. This complex cross talk is highly dependent on p53 status, as different p53 isoforms and p53 mutants can mediate different responses and even promote chronic inflammation and associated cancer, acting in the tumor cells as well as in the stromal and immune compartments. Published by Oxford University Press 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24942866      PMCID: PMC4123652          DOI: 10.1093/carcin/bgu134

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  160 in total

1.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 3.  Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.

Authors:  Samy A Azer
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 2.566

Review 4.  Inflammation meets cancer, with NF-κB as the matchmaker.

Authors:  Yinon Ben-Neriah; Michael Karin
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  p53 antagonizes the unfolded protein response and inhibits ground glass hepatocyte development during endoplasmic reticulum stress.

Authors:  Nikolina Dioufa; Ioulia Chatzistamou; Elena Farmaki; Athanasios G Papavassiliou; Hippokratis Kiaris
Journal:  Exp Biol Med (Maywood)       Date:  2012-10-04

6.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

Review 7.  Interactions between the tumor suppressor p53 and immune responses.

Authors:  Daniel Menendez; Maria Shatz; Michael A Resnick
Journal:  Curr Opin Oncol       Date:  2013-01       Impact factor: 3.645

8.  miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Cancer Res       Date:  2012-09-10       Impact factor: 12.701

Review 9.  Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect.

Authors:  Renée F Johnson; Neil D Perkins
Journal:  Trends Biochem Sci       Date:  2012-05-23       Impact factor: 13.807

10.  Proinflammatory cytokines and bile acids upregulate ΔNp73 protein, an inhibitor of p53 and p73 tumor suppressors.

Authors:  Elena Zaika; Vikas Bhardwaj; Jinxiong Wei; Mary Kay Washington; Rhonda Souza; Wael El-Rifai; Alexander Zaika
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more
  61 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

2.  Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53.

Authors:  Fayang Liu; Hongni Xue; Jie Ke; Yongyan Wu; Kezhen Yao; Shuxin Liang; Aihua Xu; Yong Zhang
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

3.  Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.

Authors:  Andrew S Venteicher; Itay Tirosh; Christine Hebert; Keren Yizhak; Cyril Neftel; Mariella G Filbin; Volker Hovestadt; Leah E Escalante; McKenzie L Shaw; Christopher Rodman; Shawn M Gillespie; Danielle Dionne; Christina C Luo; Hiranmayi Ravichandran; Ravindra Mylvaganam; Christopher Mount; Maristela L Onozato; Brian V Nahed; Hiroaki Wakimoto; William T Curry; A John Iafrate; Miguel N Rivera; Matthew P Frosch; Todd R Golub; Priscilla K Brastianos; Gad Getz; Anoop P Patel; Michelle Monje; Daniel P Cahill; Orit Rozenblatt-Rosen; David N Louis; Bradley E Bernstein; Aviv Regev; Mario L Suvà
Journal:  Science       Date:  2017-03-31       Impact factor: 47.728

4.  MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.

Authors:  Douglas D Fang; Qiuqiong Tang; Yanhui Kong; Qixin Wang; Jiaxing Gu; Xu Fang; Peng Zou; Tao Rong; Jingwen Wang; Dajun Yang; Yifan Zhai
Journal:  J Immunother Cancer       Date:  2019-11-28       Impact factor: 13.751

5.  Oncogenic pathways activated by pro-inflammatory cytokines promote mutant p53 stability: clue for novel anticancer therapies.

Authors:  Gabriella D'Orazi; Marco Cordani; Mara Cirone
Journal:  Cell Mol Life Sci       Date:  2020-10-17       Impact factor: 9.261

6.  Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation.

Authors:  Nektarios Barabutis; Mohammad A Uddin; John D Catravas
Journal:  Cytokine       Date:  2018-11-09       Impact factor: 3.861

Review 7.  Emerging roles of p53 and other tumour-suppressor genes in immune regulation.

Authors:  César Muñoz-Fontela; Anna Mandinova; Stuart A Aaronson; Sam W Lee
Journal:  Nat Rev Immunol       Date:  2016-09-26       Impact factor: 53.106

8.  Encephalitozoon cuniculi and Vittaforma corneae (Phylum Microsporidia) inhibit staurosporine-induced apoptosis in human THP-1 macrophages in vitro.

Authors:  Yuliya Y Sokolova; Lisa C Bowers; Xavier Alvarez; Elizabeth S Didier
Journal:  Parasitology       Date:  2018-11-29       Impact factor: 3.234

9.  Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.

Authors:  Kyoung Wan Yoon; Sanguine Byun; Eunjeong Kwon; So-Young Hwang; Kiki Chu; Masatsugu Hiraki; Seung-Hee Jo; Astrid Weins; Samy Hakroush; Angelika Cebulla; David B Sykes; Anna Greka; Peter Mundel; David E Fisher; Anna Mandinova; Sam W Lee
Journal:  Science       Date:  2015-07-31       Impact factor: 47.728

Review 10.  Somatic TP53 Mutations in the Era of Genome Sequencing.

Authors:  Pierre Hainaut; Gerd P Pfeifer
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.